Fanconi anemia differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Amar Morani (talk | contribs) mNo edit summary |
Amar Morani (talk | contribs) |
||
Line 45: | Line 45: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 2 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 2 | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3 | ||
|- | |||
|Fanconi Anemia | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Acquired Aplastic Anemia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Acquired Aplastic Anemia |
Revision as of 15:33, 21 June 2018
Fanconi anemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fanconi anemia differential diagnosis On the Web |
American Roentgen Ray Society Images of Fanconi anemia differential diagnosis |
Risk calculators and risk factors for Fanconi anemia differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
Differentiating X from other Diseases
- [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
- [Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].
- As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
Preferred Table
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histopathology | |||||||||||||
Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | ||||
Fanconi Anemia | |||||||||||||||
Acquired Aplastic Anemia | |||||||||||||||
Paroxysmal nocturnal hemoglobinuria (PNH) | |||||||||||||||
Other inherited bone marrow failure syndromes | |||||||||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings |
Drug-induced or infection-associated pancytopenia | |||||||||||||||
Rare chromosomal breakage syndromes | |||||||||||||||
De novo myelodysplastic syndrome (MDS) |